ESC/EACTS Page 35 <strong>of</strong> 34 AN. Effect <strong>of</strong> intensive compared with moderate lipid-lowering therapy on progression <strong>of</strong> coronary atherosclerosis: a randomized controlled trial. JAMA 2004;291(9):1071-1080. Ostojic M, Picano E, Beleslin B, Dordjevic-Dikic A, Distante A, Stepanovic J, Reisenh<strong>of</strong>er B, Babic R, Stojkovic S, Nedeljkovic M, . Dipyridamole-dobutamine echocardiography: a novel test for the detection <strong>of</strong> milder forms <strong>of</strong> coronary artery disease. J Am Coll Cardiol 1994;23(5):1115-1122. Patel MR, Dehmer GJ, Hirshfeld JW, Smith PK, Spertus JA. ACCF/ SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: a report by the American College <strong>of</strong> <strong>Cardiology</strong> Foundation Appropriateness Criteria Task Force, <strong>Society</strong> for Cardiovascular Angiography and Interventions, <strong>Society</strong> <strong>of</strong> Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American <strong>Society</strong> <strong>of</strong> Nuclear <strong>Cardiology</strong> Endorsed by the American <strong>Society</strong> <strong>of</strong> Echocardiography, the Heart Failure <strong>Society</strong> <strong>of</strong> America, and the <strong>Society</strong> <strong>of</strong> Cardiovascular Computed Tomography. J Am Coll Cardiol 2009;53(6):530-553. Pelliccia A, Fagard R, Bjornstad HH, Anastassakis A, Arbustini E, Assanelli D, Biffi A, Borjesson M, Carre F, Corrado D, Delise P, Dorwarth U, Hirth A, Heidbuchel H, H<strong>of</strong>fmann E, Mellwig KP, Panhuyzen-Goedkoop N, Pisani A, Solberg EE, van-Buuren F, Vanhees L, Blomstrom-Lundqvist C, Deligiannis A, Dugmore D, Glikson M, H<strong>of</strong>f PI, H<strong>of</strong>fmann A, H<strong>of</strong>fmann E, Horstkotte D, Nordrehaug JE, Oudh<strong>of</strong> J, McKenna WJ, Penco M, Priori S, Reybrouck T, Senden J, Spataro A, Thiene G. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group <strong>of</strong> Sports <strong>Cardiology</strong> <strong>of</strong> the Working Group <strong>of</strong> Cardiac Rehabilitation and Exercise Physiology and the Working Group <strong>of</strong> Myocardial and Pericardial Diseases <strong>of</strong> the <strong>European</strong> <strong>Society</strong> <strong>of</strong> <strong>Cardiology</strong>. Eur Heart J 2005;26(14):1422-1445. Pelliccia A, Zipes DP, Maron BJ. Bethesda Conference #36 and the <strong>European</strong> <strong>Society</strong> <strong>of</strong> <strong>Cardiology</strong> Consensus Recommendations revisited a comparison <strong>of</strong> U.S. and <strong>European</strong> criteria for eligibility and disqualification <strong>of</strong> competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol 2008;52(24):1990-1996. Pfisterer M, Rickenbacher P, Kiowski W, Muller-Brand J, Burkart F. Silent ischemia after percutaneous transluminal coronary angioplasty: incidence and prognostic significance. J Am Coll Cardiol 1993;22(5):1446-1454. Picano E. Informed consent and communication <strong>of</strong> risk from radiological and nuclear medicine examinations: how to escape from a communication inferno. BMJ 2004;329(7470):849-851. Pitt B, Waters D, Brown WV, van Boven AJ, Schwartz L, Title LM, Eisenberg D, Shurzinske L, McCormick LS. Aggressive lipidlowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. N Engl J Med 1999;341(2):70-76. Rigo F. Coronary flow reserve in stress-echo lab. From pathophysiologic toy to diagnostic tool. Cardiovasc Ultrasound 2005;3:8. Ropers D, Pohle FK, Kuettner A, Pflederer T, Anders K, Daniel WG, Bautz W, Baum U, Achenbach S. Diagnostic accuracy <strong>of</strong> noninvasive coronary angiography in patients after bypass surgery using 64-slice spiral computed tomography with 330-ms gantry rotation. Circulation 2006;114(22):2334-2341. Salm LP, Bax JJ, Jukema JW, Schuijf JD, Vliegen HW, Lamb HJ, van der Wall EE, de RA. Comprehensive assessment <strong>of</strong> patients after coronary artery bypass grafting by 16-detector-row computed tomography. Am Heart J 2005;150(4):775-781. Saraste M, Koskenvuo JW, Mikkola J, Pelttari L, Toikka JO, Hartiala JJ. Technical achievement: transthoracic Doppler echocardiography can be used to detect LAD restenosis after coronary angioplasty. Clin Physiol 2000;20(6):428-433. Saraste M, Vesalainen RK, Ylitalo A, Saraste A, Koskenvuo JW, Toikka JO, Vaittinen MA, Hartiala JJ, Airaksinen KE. Transthoracic Doppler echocardiography as a noninvasive tool to assess coronary artery stenoses--a comparison with quantitative coronary angiography. J Am Soc Echocardiogr 2005;18(6):679-685. Senior R, Becher H, Monaghan M, Agati L, Zamorano J, Vanoverschelde JL, Nihoyannopoulos P. Contrast echocardiography: evidence-based recommendations by <strong>European</strong> Association <strong>of</strong> Echocardiography. Eur J Echocardiogr 2009;10:194-212. Serruys PW, De FP, Macaya C, Kokott N, Puel J, Vrolix M, Branzi A, Bertolami MC, Jackson G, Strauss B, Meier B. Fluvastatin for prevention <strong>of</strong> cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;287(24):3215-3222. Sicari R, Nihoyannopoulos P, Evangelista A, Kasprzak J, Lancellotti P, Poldermans D, Voigt JU, Zamorano JL. Stress Echocardiography Expert Consensus Statement--Executive Summary: <strong>European</strong> Association <strong>of</strong> Echocardiography (EAE) (a registered branch <strong>of</strong> the ESC). Eur Heart J 2009;30(3):278-289. Stauder NI, Kuttner A, Schroder S, Drosch T, Beck T, Stauder H, Blumenstock G, Claussen CD, Kopp AF. Coronary artery bypass grafts: assessment <strong>of</strong> graft patency and native coronary artery lesions using 16-slice MDCT. Eur Radiol 2006;16(11):2512-2520.
For more information www.escardio.org/guidelines © 2010 The <strong>European</strong> <strong>Society</strong> <strong>of</strong> <strong>Cardiology</strong> No part <strong>of</strong> this document may be translated or reproduced in any form without written permission from the ESC. The following material was adapted from the Joint ESC-EACTS Guidelines on Myocardial Revascularisation (<strong>European</strong> Heart Journal 2010 - doi:10.1093/eurheartj/ehq277 & <strong>European</strong> Journal <strong>of</strong> Cardio-Thoracic Surgery 2010 - doi:10.1016/j.ejcts.2010.08.019). To read the full report as published by the <strong>European</strong> <strong>Society</strong> <strong>of</strong> <strong>Cardiology</strong>, visit our Web Site at: www.escardio.org/guidelines copyright © european society <strong>of</strong> cardiology 2010 - all rights reserved. The content <strong>of</strong> these <strong>European</strong> <strong>Society</strong> <strong>of</strong> <strong>Cardiology</strong> (ESC) Guidelines has been published for personal and educational use only. No commercial use is authorized. No part <strong>of</strong> the ESC Guidelines may be translated or reproduced in any form without written permission from the ESC. Permission can be obtained upon submission <strong>of</strong> a written request to ESC, Practice Guidelines Department, 2035, route des Colles - Les Templiers - BP179 - 06903 Sophia Antipolis Cedex - France. disclaimer: The ESC Guidelines represent the views <strong>of</strong> the ESC which were arrived at after careful consideration <strong>of</strong> the available evidence at the time they were written. Health pr<strong>of</strong>essionals are encouraged to take them fully into account when exercising their clinical judgment. The guidelines do not, however, override the individual responsibility <strong>of</strong> health pr<strong>of</strong>essionals to make appropriate decisions in the circumstances <strong>of</strong> the individual patients, in consultation with that patient, and where appropriate and necessary the patient’s guardian or carer. It is also the health pr<strong>of</strong>essional’s responsibility to verify the rules and regulations applicable to drugs and devices at the time <strong>of</strong> prescription.
Change language